Status:
COMPLETED
Evaluation of the Level and Prognostic Relevance of New Neuroinflammation Markers in Subarachnoid Haemorrhage
Lead Sponsor:
Azienda Ospedaliero Universitaria Maggiore della Carita
Conditions:
Subarachnoid Hemorrhage
Eligibility:
All Genders
18-80 years
Brief Summary
Subarachnoid hemorrhage (SAH) consists of blood extravasation into the space between arachnoid and pia mater. Bleeding is a consequence of cerebral aneurysm rupture in most cases. Despite incidence be...
Detailed Description
Subarachnoid hemorrhage (SAH) consists of blood extravasation into the space between arachnoid and pia mater. Bleeding is a consequence of cerebral aneurysm rupture in most cases. It particularly affe...
Eligibility Criteria
Inclusion
- Age between 18 and 80 years
- Subarachnoid haemorrhage from cerebral aneurysm rupture
- Indication to external liquor drainage
Exclusion
- Age less than 18 or more than 80 years
- Bleeding occurred more than 24 hours before admission
- Known coagulopathies or antiplatelet or vitamin K antagonist treatment
Key Trial Info
Start Date :
January 26 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03411746
Start Date
January 26 2018
End Date
July 31 2019
Last Update
February 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rosanna Vaschetto
Novara, Italy, 28100